SCHEMBL216078

SCHEMBL216078

CN(C)CCN1C(=O)Cc2c[c]ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 5/20 0.44
SLC6A4 P31645 4/20 0.44
HTR7 P34969 6/20 0.38
DRD2 P14416 4/20 0.38
HTR6 P50406 4/20 0.38
LMNA P02545 4/20 0.38
MAPT P10636 4/20 0.38
HTR1A P08908 4/20 0.38
HTR2A P28223 3/20 0.38
CHRM2 P08172 2/20 0.38
DRD1 P21728 2/20 0.38
SLC6A2 P23975 2/20 0.38
ADRA1A P35348 2/20 0.38
OPRM1 P35372 2/20 0.38
DRD3 P35462 2/20 0.38
ADRA2A P08913 1/20 0.38
KDM4E B2RXH2 3/20 0.37
CYP2D6 P10635 2/20 0.37
CACNA1S Q13698 2/20 0.37
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6704468 0.80 HRH1 (0.61) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL24603093 0.77 HRH1 (0.44) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL217201 0.76 NOS3 (0.47) HRH1SLC6A4DRD2HTR2AALDH1A1
SCHEMBL3483234 0.76 TRIM24 (0.39) LMNAALDH1A1
SCHEMBL16064620 0.75 SLC6A4 (0.43) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL8510313 0.75 ATAD2 (0.50) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL9854057 0.73 CACNA1S (0.53) HRH1SLC6A4HTR2AKDM4ECACNA1S
SCHEMBL16064594 0.72 SIGMAR1 (0.43) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL12682781 0.72 HTR7 (0.68) HRH1SLC6A4HTR7DRD2HTR6
SCHEMBL215105 0.72 ALDH1A1 (0.63) HRH1SLC6A4HTR7DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK HRH1 2283/4885SLC6A4 4750/4885HTR7 4068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.